Business ❯ Corporate Governance ❯ Shareholder Rights

Investor Relations

Class Action Participation Class Action Lawsuits Stockholder Actions Securities Fraud Financial Reporting Stock Performance Legal Notices Legal Representation Annual General Meetings Public Companies

Medpace Faces New Investor Class Action Over Book‑to‑Bill and Cancellations

The cases turn on whether Medpace hid rising cancellations in a key orders-to-revenue metric investors use to gauge future growth.

Super Micro Investors Sought to Lead Securities Suits After DOJ Export-Control Indictment

Coty Investors Face May 22 Deadline To Seek Lead Role In Securities Class Action

Alight Investors Get May 15 Deadline to Seek Lead Role in Securities Case

Pinterest Faces Securities Class Action Over Tariff-Linked Ad Slump Disclosures

Law Firms Seek Ultragenyx Investors to Lead Securities Class Actions After OI Trial Miss

Boston Scientific Investors Get May 4 Deadline to Seek Lead Role in Securities Suit

Driven Brands Investors Face May 8 Deadline in Securities Class Action Over Accounting Errors

Investor Lawsuits Target Navan’s IPO Disclosures With Lead-Plaintiff Deadline on April 24

Klarna IPO Investors Face Feb. 20 Deadline to Seek Lead Role in E.D.N.Y. Securities Case

Endeavor Hit With Securities Class Action Challenging $27.50 Take‑Private

U.S. Judge Dismisses CrowdStrike Investor Fraud Suit Over 2024 Outage

SLM Investors Reminded of Feb. 17 Deadline to Seek Lead-Plaintiff Role in Securities Case

Law Firms Escalate Investor Actions Over F5 Breach Disclosures as Lead‑Plaintiff Deadline Nears

F5 Investors Face Feb. 17 Deadline in Securities Case Over Nation‑State Breach Disclosure

Integer Faces Investor Class Action in SDNY as Firms Press Feb. 9 Lead-Plaintiff Deadline

Integer Holdings Faces Securities Class Action Over Electrophysiology Outlook

Inspire Medical Faces Investor Class Actions Over Inspire V Rollout

Musk Moves to Dismiss SEC Suit Over 2022 Twitter Stake Disclosure

GKB Ophthalmics AGM Outburst Goes Viral as Stake Dispute Persists and Vijay Kedia Weighs In